Bayer
拜耳
elsewhere's corpus does not cover this subject. The bundle contains only a single passing mention of Bayer as a pharmaceutical company that partnered with Naxions (诺信创联), per a 2020 峰瑞资本 piece , with no substantive profile of Bayer itself.
AI-generated — may contain errors, please verify.
Coverage
When a Billion AIs Simulate the Future Together: The New Bet Fei-Fei Li and Karpathy Are Both Making | 5Y Research
When One Billion AIs Simulate the Future Together: A New $1 Billion Series A Track, Co-Bet by Fei-Fei Li and Karpathy
Biomanufacturing: Who Can Move Faster on the New Research Paradigm?
A Conversation with Professor Liu Tiangang on Future Industries: Biomanufacturing
Li Xilie: Former Head of Bayer and Medtronic Asia-Pacific on Nine Strategies for Chinese Healthcare Companies Going Global | Ronghui Practical Insights
"Nine Questions" for Chinese Healthcare Companies Going Global
OpenAI Releases GPT-4o mini: Faster and Cheaper
Speed is justice.
Everything Has Two Sides: How Can "Nuclear Radiation" Be Used to Make Anti-Cancer Drugs? | FreeS Report 28
Now is the spring of radiopharmaceuticals.
Medicine Is the Science of Uncertainty and the Art of Possibility | 5Y Talk × Sihui Ma Xuguang
Illness is part of being human, and humans are part of society.
Linear Capital News | Linear Capital-led Pre-A round portfolio company "Akenong" announces over 100 million RMB funding round, with Linear Capital continuing to increase its support
On June 23, 2022, Aicron, China's first smart crop cultivation decision-making service provider, announced the completion of two consecutive funding rounds — a Series A and a Series A+ — totaling over RMB 100 million. The Series A was led by Source Code Capital, while the Series A+ was jointly led by IDG Capital and Hillhouse. Linear Capital and Bits x Bites participated in both rounds as co-investors.
5Y News｜Vivace Therapeutics Announces Completion of Angel Round Raising Tens of Millions of RMB
Huanyi Bio announced the completion of an angel funding round of tens of millions of RMB, led by 5Y Capital.
Network Effects — Possibly One of the Best SaaS Business Models | Frees Fund: Learning from Investing
Tough businesses that address long-standing contradictions always represent outsized opportunities.
